N
NARI

Natixis’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Natixis’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-94,500
Closed -$4.82M – 1225
2024
Q4 		$4.82M Buy
+94,500
New +$4.64M 0.03% 343
2024
Q1 		– Sell
-9,559
Closed -$621K – 1266
2023
Q4 		$621K Sell
9,559
-2,271
-19% -$137K ﹤0.01% 588
2023
Q3 		$774K Sell
11,830
-1,880
-14% -$118K 0.01% 544
2023
Q2 		$797K Sell
13,710
-78
-0.6% -$4.92K 0.01% 581
2023
Q1 		$851K Buy
+13,788
New +$827K 0.01% 550

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Natixis's NARI Position: Q1 2025 in Review

Natixis sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 94,500 shares — an estimated $4.82M sold.

Natixis first reported a position in NARI in Q1 2023 and held it in 5 quarters. The position peaked at $4.82M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Natixis reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Natixis sold 94,500 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $4.82M.
  • Natixis first reported a position in Inari Medical, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
  • Natixis's Inari Medical, Inc. Common Stock position peaked at $4.82M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Natixis's 13F filing for Q1 2025, filed 14 May 2025.